Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate)
NCT ID: NCT02530541
Last Updated: 2021-04-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
33 participants
INTERVENTIONAL
2014-04-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Trial of Chlorhexidine Gluconate (CHG) Preoperative Skin Preparation
NCT02530554
Pilot Trial of Preoperative Chlorhexidine Gluconate (CHG) Skin Preparation
NCT02530528
Pilot Clinical Trial - Comparative Study of Two Material Concentration of OD-141309
NCT04703335
In Vivo Efficacy Study of Patient Preoperative Preps
NCT02203591
A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients
NCT03030989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CHG 1 min
1 min application time
CHG
Varied application times
CHG 2 min
2 min application time
CHG
Varied application times
Comparator CHG
Marketed CHG
CHG
Varied application times
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CHG
Varied application times
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No dermatological conditions
Exclusion Criteria
* Sensitivity to natural latex rubber or adhesive skin products
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medline Industries
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esther Campbell
Role: PRINCIPAL_INVESTIGATOR
Bioscience Labs
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R14-015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.